The comparative analysis of enteral ordinary nutrition and enteral immune nutrition in postoperative nutritional support to the gastric cancer patients
Qian Hong-ju
Abstract
Qian Hong-ju
Abstract
OBJECTIVE To compare the postoperative nutritional support between enteral ordinary nutrition and enteral immune nutrition to the gastric cancer patients. METHODS This study included 30 gastric cancer patients who needed operation in our hospital from January 2008 to December 2011. According to the single-blind digital form method , the patients were randomly divided into enteral ordinary nutrition group (EON group) and enteral immune nutrition group (EIN group). The EON group had 15 cases who were provided with enteral ordinary nutrition after the operation. The EIN group had 15 cases who were provided with enteral immune nutrition after the operation. Changes in nutritional indexes and immune indexes 1d , 9d after the operation were recorded. RESULTS (1) One day after the operation, serum total protein, albumin, prealbumin and transferrin concentration were not significantly different between two groups (P﹥0.05). Nine days after the operation, serum total protein, albumin concentration were significantly different between the two groups (P﹤0.05) , but albumin and transferrin were not different between the two groups (P﹥0.05). (2) One day after the operation, IgG, IgA, IgM, CD3, CD4, CD8 were not significantly different between the two groups (P﹥0.05). Nine days after the operation, IgG, IgA, IgM, CD3, CD4 were significantly different between the two groups (P﹤0.05), and CD8 was not significantly different between the two groups (P﹥0.05). CONCLUSION As compared to enteral ordinary nutrition, enteral immune nutrition has a better ability to increase immune function and has specific immune reinforcing agent to effectively protect and improve the immune function of patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To compare the postoperative nutritional support between enteral ordinary nutrition and enteral immune nutrition to the gastric cancer patients. METHODS This study included 30 gastric cancer patients who needed operation in our hospital from January 2008 to December 2011. According to the single-blind digital form method , the patients were randomly divided into enteral ordinary nutrition group (EON group) and enteral immune nutrition group (EIN group). The EON group had 15 cases who were provided with enteral ordinary nutrition after the operation. The EIN group had 15 cases who were provided with enteral immune nutrition after the operation. Changes in nutritional indexes and immune indexes 1d , 9d after the operation were recorded. RESULTS (1) One day after the operation, serum total protein, albumin, prealbumin and transferrin concentration were not significantly different between two groups (P﹥0.05). Nine days after the operation, serum total protein, albumin concentration were significantly different between the two groups (P﹤0.05) , but albumin and transferrin were not different between the two groups (P﹥0.05). (2) One day after the operation, IgG, IgA, IgM, CD3, CD4, CD8 were not significantly different between the two groups (P﹥0.05). Nine days after the operation, IgG, IgA, IgM, CD3, CD4 were significantly different between the two groups (P﹤0.05), and CD8 was not significantly different between the two groups (P﹥0.05). CONCLUSION As compared to enteral ordinary nutrition, enteral immune nutrition has a better ability to increase immune function and has specific immune reinforcing agent to effectively protect and improve the immune function of patients.
Key concepts: Parenteral nutrition, Medicine, Enteral administration, Immune system, Gastroenterology, Transferrin, Internal medicine, Transthyretin